These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|||||||
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |||||||
|
|
|||||||
(Address of principal executive offices) | (Zip Code) | |||||||
(
|
||||||||
Registrant’s telephone number, including area code | ||||||||
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
|
|
|
|
x | Accelerated Filer | ☐ | ||||||||
Non-Accelerated Filer | ¨ | Smaller reporting company |
|
||||||||
Emerging growth company |
|
Page | ||||||||
PART I | ||||||||
Item 1. | ||||||||
Condensed Consolidated Balance Sheets as of
September 30, 2023 (unaudited) and December 31, 2022
|
||||||||
Condensed Consolidated Statements of Operations (unaudited) for the
Three and Nine Months Ended September 30, 2023 and 2022
|
||||||||
Condensed Consolidated Statements of Stockholders’ Equity (unaudited) for
the Three and Nine Months Ended September 30, 2023 and 2022
|
||||||||
Condensed Consolidated Statements of Cash Flows (unaudited) for
the Nine Months Ended September 30, 2023 and 2022
|
||||||||
1
7
. Segment I
nformation
|
||||||||
Item 2. | ||||||||
Item 3. | ||||||||
Item 4. | ||||||||
PART II | ||||||||
Item 1. | ||||||||
Item 1A. | ||||||||
Item 2. | ||||||||
Item 3. | ||||||||
Item 4. | ||||||||
Item 5. | ||||||||
Item 6. |
September 30, 2023 | December 31, 2022 | ||||||||||
(unaudited) | |||||||||||
Assets | |||||||||||
Cash and cash equivalents | $ |
|
$ |
|
|||||||
Restricted cash |
|
|
|||||||||
Mortgage servicing rights at fair value |
|
|
|||||||||
Advances and other receivables, net of reserves of $
|
|
|
|||||||||
Mortgage loans held for sale at fair value |
|
|
|||||||||
Property and equipment, net of accumulated depreciation of $
|
|
|
|||||||||
Deferred tax assets, net |
|
|
|||||||||
Other assets |
|
|
|||||||||
Total assets | $ |
|
$ |
|
|||||||
Liabilities and Stockholders’ Equity | |||||||||||
Unsecured senior notes, net | $ |
|
$ |
|
|||||||
Advance, warehouse and MSR facilities, net |
|
|
|||||||||
Payables and other liabilities |
|
|
|||||||||
MSR related liabilities - nonrecourse at fair value |
|
|
|||||||||
Total liabilities |
|
|
|||||||||
Commitments and contingencies (Note 16) |
|
|
|||||||||
Common stock at $
|
|
|
|||||||||
Additional paid-in-capital |
|
|
|||||||||
Retained earnings |
|
|
|||||||||
Treasury shares at cost -
|
(
|
(
|
|||||||||
Total stockholders’ equity |
|
|
|||||||||
Total liabilities and stockholders’ equity | $ |
|
$ |
|
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
Revenues: | |||||||||||||||||||||||
Service related, net | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Net gain on mortgage loans held for sale |
|
|
|
|
|||||||||||||||||||
Total revenues |
|
|
|
|
|||||||||||||||||||
Expenses: | |||||||||||||||||||||||
Salaries, wages and benefits |
|
|
|
|
|||||||||||||||||||
General and administrative |
|
|
|
|
|||||||||||||||||||
Total expenses |
|
|
|
|
|||||||||||||||||||
Interest income |
|
|
|
|
|||||||||||||||||||
Interest expense |
(
|
(
|
(
|
(
|
|||||||||||||||||||
Other income (expense), net |
|
(
|
|
|
|||||||||||||||||||
Total other income (expense), net |
|
(
|
|
|
|||||||||||||||||||
Income before income tax expense |
|
|
|
|
|||||||||||||||||||
Less: Income tax expense |
|
|
|
|
|||||||||||||||||||
Net income | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Earnings per share | |||||||||||||||||||||||
Basic | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Diluted | $ |
|
$ |
|
$ |
|
$ |
|
Common Stock | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares
(in thousands) |
Amount | Additional Paid-in Capital | Retained Earnings | Treasury Share Amount | Total Mr. Cooper Stockholders’ Equity | Non-controlling Interests |
Total Stockholders’
Equity |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance at June 30, 2022 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||||||||||||||||||||||
Shares issued / (surrendered) under incentive compensation plan |
|
— |
(
|
— |
|
(
|
— |
(
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based compensation | — | — |
|
— | — |
|
— |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dividends paid to noncontrolling interests | — | — | — | — | — | — |
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Repurchase of common stock |
(
|
— | — | — |
(
|
(
|
— |
(
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net income | — | — | — |
|
— |
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance at September 30, 2022 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||||||||||||||||||||||
Balance at June 30, 2023 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||||||||||||||||||||||
Shares issued / (surrendered) under incentive compensation plan |
|
— |
(
|
— |
|
|
— |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based compensation | — | — |
|
— | — |
|
— |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Repurchase of common stock |
(
|
— | — | — |
(
|
(
|
— |
(
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net income | — | — | — |
|
— |
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance at September 30, 2023 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
Common Stock | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares
(in thousands) |
Amount | Additional Paid-in Capital | Retained Earnings | Treasury Share Amount | Total Mr. Cooper Stockholders’ Equity | Non-controlling Interests |
Total Stockholders’
Equity |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance at January 1, 2022 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||||||||||||||||||||||
Shares issued / (surrendered) under incentive compensation plan |
|
— |
(
|
— |
|
(
|
— |
(
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based compensation | — | — |
|
— | — |
|
— |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dividends paid to noncontrolling interests | — | — | — | — | — | — |
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Repurchase of common stock |
(
|
— | — | — |
(
|
(
|
— |
(
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net income | — | — | — |
|
— |
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance at September 30, 2022 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||||||||||||||||||||||
Balance at January 1, 2023 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||||||||||||||||||||||
Shares issued / (surrendered) under incentive compensation plan |
|
— |
(
|
— |
|
(
|
— |
(
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based compensation | — | — |
|
— | — |
|
— |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Repurchase of common stock |
(
|
— | — | — |
(
|
(
|
— |
(
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net income | — | — | — |
|
— |
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance at September 30, 2023 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
Nine Months Ended September 30, | |||||||||||
2023 | 2022 | ||||||||||
Operating Activities | |||||||||||
Net income | $ |
|
$ |
|
|||||||
Adjustments to reconcile net income to net cash attributable to operating activities: | |||||||||||
Deferred tax expense |
|
|
|||||||||
Net gain on mortgage loans held for sale |
(
|
(
|
|||||||||
Provision for servicing and non-servicing reserves |
|
|
|||||||||
Fair value changes in mortgage servicing rights |
|
(
|
|||||||||
Fair value changes in MSR related liabilities |
(
|
|
|||||||||
Depreciation and amortization for property and equipment and intangible assets |
|
|
|||||||||
Gain on disposition of assets |
|
(
|
|||||||||
Bargain purchase gain |
(
|
|
|||||||||
Loss on MSR hedging activities |
|
|
|||||||||
(Gain) loss on MSR sales |
(
|
|
|||||||||
Other operating activities |
|
|
|||||||||
Repurchases of loan assets out of Ginnie Mae securitizations |
(
|
(
|
|||||||||
Mortgage loans originated and purchased for sale, net of fees |
(
|
(
|
|||||||||
Sales proceeds and loan payment proceeds for mortgage loans held for sale |
|
|
|||||||||
Changes in assets and liabilities: | |||||||||||
Advances and other receivables |
|
|
|||||||||
Other assets |
(
|
|
|||||||||
Payables and other liabilities |
(
|
(
|
|||||||||
Net cash attributable to operating activities |
|
|
|||||||||
Investing Activities | |||||||||||
Acquisitions of business, net of cash acquired |
(
|
|
|||||||||
Acquisition of assets |
(
|
|
|||||||||
Property and equipment additions, net of disposals |
(
|
(
|
|||||||||
Purchase of mortgage servicing rights |
(
|
(
|
|||||||||
Proceeds on sale of mortgage servicing rights and excess yield |
|
|
|||||||||
Other investing activities |
(
|
|
|||||||||
Net cash attributable to investing activities |
(
|
(
|
|||||||||
Financing Activities | |||||||||||
Increase (decrease) in advance, warehouse and MSR facilities |
|
(
|
|||||||||
Settlements and repayment of excess spread financing |
(
|
(
|
|||||||||
Repurchase of common stock |
(
|
(
|
|||||||||
Other financing activities |
(
|
(
|
|||||||||
Net cash attributable to financing activities |
|
(
|
|||||||||
Net increase (decrease) in cash, cash equivalents, and restricted cash |
|
(
|
|||||||||
Cash, cash equivalents, and restricted cash - beginning of period |
|
|
|||||||||
Cash, cash equivalents, and restricted cash - end of period
(1)
|
$ |
|
$ |
|
|||||||
Supplemental Disclosures of Non-cash Investing Activities | |||||||||||
Equity consideration received from disposition of assets | $ |
|
$ |
|
|||||||
Purchase of mortgage servicing rights | $ |
|
$ |
|
|||||||
Mortgage servicing rights sales price holdback | $ |
|
$ |
|
September 30, 2023 | September 30, 2022 | ||||||||||
Cash and cash equivalents | $ |
|
$ |
|
|||||||
Restricted cash |
|
|
|||||||||
Total cash, cash equivalents, and restricted cash | $ |
|
$ |
|
MSRs and Related Liabilities | September 30, 2023 | December 31, 2022 | |||||||||
MSRs - fair value | $ |
|
$ |
|
|||||||
Excess spread financing at fair value | $ |
|
$ |
|
|||||||
Mortgage servicing rights financing at fair value |
|
|
|||||||||
MSR related liabilities - nonrecourse at fair value | $ |
|
$ |
|
Nine Months Ended September 30, | ||||||||||||||||||||
MSRs - Fair Value | 2023 | 2022 | ||||||||||||||||||
Fair value - beginning of period | $ |
|
$ |
|
||||||||||||||||
Additions: | ||||||||||||||||||||
Servicing retained from mortgage loans sold |
|
|
||||||||||||||||||
Purchases and acquisitions of servicing rights |
|
|
||||||||||||||||||
Dispositions: | ||||||||||||||||||||
Sales of servicing assets and excess yield |
(
|
(
|
||||||||||||||||||
Changes in fair value: | ||||||||||||||||||||
Changes in valuation inputs or assumptions used in the valuation model (MSR MTM) |
|
|
||||||||||||||||||
Changes in valuation due to amortization |
(
|
(
|
||||||||||||||||||
Other changes
(1)
|
|
|
||||||||||||||||||
Fair value - end of period | $ |
|
$ |
|
September 30, 2023 | December 31, 2022 | ||||||||||||||||||||||
MSRs - UPB and Fair Value Breakdown by Investor Pools | UPB | Fair Value | UPB | Fair Value | |||||||||||||||||||
Agency | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Non-agency |
|
|
|
|
|||||||||||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
Option Adjusted Spread
(1)
|
Total Prepayment Speeds
|
Cost to Service per Loan | |||||||||||||||||||||||||||||||||
MSRs - Hypothetical Sensitivities |
100 bps
Adverse
Change
|
200 bps
Adverse
Change
|
10%
Adverse
Change
|
20%
Adverse
Change
|
10%
Adverse
Change
|
20%
Adverse
Change
|
|||||||||||||||||||||||||||||
September 30, 2023 | |||||||||||||||||||||||||||||||||||
Mortgage servicing rights | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||||||||||
Discount Rate |
Total Prepayment Speeds
|
Cost to Service per Loan | |||||||||||||||||||||||||||||||||
MSRs - Hypothetical Sensitivities |
100 bps
Adverse
Change
|
200 bps
Adverse
Change
|
10%
Adverse
Change
|
20%
Adverse
Change
|
10%
Adverse
Change
|
20%
Adverse
Change
|
|||||||||||||||||||||||||||||
December 31, 2022 | |||||||||||||||||||||||||||||||||||
Mortgage servicing rights | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
Option Adjusted Spread
(1)
|
Prepayment Speeds
|
||||||||||||||||||||||
Excess Spread Financing - Hypothetical Sensitivities |
100 bps
Adverse
Change
|
200 bps
Adverse
Change
|
10%
Adverse
Change
|
20%
Adverse
Change
|
|||||||||||||||||||
September 30, 2023 | |||||||||||||||||||||||
Excess spread financing | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Discount Rate |
Prepayment Speeds
|
||||||||||||||||||||||
Excess Spread Financing - Hypothetical Sensitivities |
100 bps
Adverse
Change
|
200 bps
Adverse
Change
|
10%
Adverse
Change
|
20%
Adverse
Change
|
|||||||||||||||||||
December 31, 2022 | |||||||||||||||||||||||
Excess spread financing | $ |
|
$ |
|
$ |
|
$ |
|
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
Revenues - Service Related, net | 2023 | 2022 | 2023 | 2022 | |||||||||||||||||||
Contractually specified servicing fees
(1)
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Other service-related income
(1)
|
|
|
|
|
|||||||||||||||||||
Incentive and modification income
(1)
|
|
|
|
|
|||||||||||||||||||
Servicing late fees
(1)
|
|
|
|
|
|||||||||||||||||||
Mark-to-market adjustments - Servicing | |||||||||||||||||||||||
MSR MTM |
|
|
|
|
|||||||||||||||||||
Loss on MSR hedging activities |
(
|
(
|
(
|
(
|
|||||||||||||||||||
(Loss) gain on MSR sales |
(
|
(
|
|
(
|
|||||||||||||||||||
Reclassifications
(2)
|
(
|
(
|
(
|
(
|
|||||||||||||||||||
Excess spread / MSR financing MTM |
(
|
(
|
|
(
|
|||||||||||||||||||
Total mark-to-market adjustments - Servicing |
|
|
|
|
|||||||||||||||||||
Amortization, net of accretion | |||||||||||||||||||||||
MSR amortization |
(
|
(
|
(
|
(
|
|||||||||||||||||||
Excess spread accretion |
|
|
|
|
|||||||||||||||||||
Total amortization, net of accretion |
(
|
(
|
(
|
(
|
|||||||||||||||||||
Originations service fees
(3)
|
|
|
|
|
|||||||||||||||||||
Corporate/Xome related service fees |
|
|
|
|
|||||||||||||||||||
Other
(4)
|
(
|
(
|
(
|
(
|
|||||||||||||||||||
Total revenues - Service Related, net | $ |
|
$ |
|
$ |
|
$ |
|
Advances and Other Receivables, Net | September 30, 2023 | December 31, 2022 | |||||||||
Servicing advances, net of $
|
$ |
|
$ |
|
|||||||
Receivables from agencies, investors and prior servicers, net of $
|
|
|
|||||||||
Reserves |
(
|
(
|
|||||||||
Total advances and other receivables, net | $ |
|
$ |
|
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
Reserves for Advances and Other Receivables | 2023 | 2022 | 2023 | 2022 | |||||||||||||||||||
Balance - beginning of period | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Provision |
|
|
|
|
|||||||||||||||||||
Reclassifications
(1)
|
|
|
|
|
|||||||||||||||||||
Write-offs |
(
|
(
|
(
|
(
|
|||||||||||||||||||
Balance - end of period | $ |
|
$ |
|
$ |
|
$ |
|
Three Months Ended September 30, | |||||||||||||||||||||||
2023 | 2022 | ||||||||||||||||||||||
Purchase Discount for Advances and Other Receivables | Servicing Advances | Receivables from Agencies, Investors and Prior Servicers | Servicing Advances | Receivables from Agencies, Investors and Prior Servicers | |||||||||||||||||||
Balance - beginning of period | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Addition from acquisition
(1)
|
|
|
|
|
|||||||||||||||||||
Utilization of purchase discounts |
(
|
|
(
|
(
|
|||||||||||||||||||
Balance - end of period | $ |
|
$ |
|
$ |
|
$ |
|
Nine Months Ended September 30, | |||||||||||||||||||||||
2023 | 2022 | ||||||||||||||||||||||
Purchase Discount for Advances and Other Receivables | Servicing Advances | Receivables from Agencies, Investors and Prior Servicers | Servicing Advances | Receivables from Agencies, Investors and Prior Servicers | |||||||||||||||||||
Balance - beginning of period | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Addition from acquisition
(1)
|
|
|
|
|
|||||||||||||||||||
Utilization of purchase discounts |
(
|
|
(
|
(
|
|||||||||||||||||||
Balance - end of period | $ |
|
$ |
|
$ |
|
$ |
|
Mortgage Loans Held for Sale | September 30, 2023 | December 31, 2022 | |||||||||
Mortgage loans held for sale – UPB | $ |
|
$ |
|
|||||||
Mark-to-market adjustment
(1)
|
(
|
(
|
|||||||||
Total mortgage loans held for sale | $ |
|
$ |
|
Nine Months Ended September 30, | |||||||||||
Mortgage Loans Held for Sale | 2023 | 2022 | |||||||||
Balance - beginning of period | $ |
|
$ |
|
|||||||
Loans sold and loan payments received |
(
|
(
|
|||||||||
Mortgage loans originated and purchased, net of fees |
|
|
|||||||||
Repurchase of loans out of Ginnie Mae securitizations
(1)
|
|
|
|||||||||
Net change in unrealized gain (loss) on retained loans held for sale |
|
(
|
|||||||||
Net transfers of mortgage loans held for sale
(2)
|
(
|
|
|||||||||
Balance - end of period | $ |
|
$ |
|
September 30, 2023 | December 31, 2022 | ||||||||||||||||||||||
Mortgage Loans Held for Sale | UPB | Fair Value | UPB | Fair Value | |||||||||||||||||||
Non-accrual
(1)
|
$ |
|
$ |
|
$ |
|
$ |
|
September 30, 2023 | Nine Months Ended September 30, 2023 | ||||||||||||||||||||||
Derivative Financial Instruments |
Expiration
Dates |
Outstanding
Notional |
Fair
Value |
Gains/(Losses) | |||||||||||||||||||
Assets | |||||||||||||||||||||||
Mortgage loans held for sale | |||||||||||||||||||||||
Loan sale commitments | 2023 | $ |
|
$ |
|
$ |
(
|
||||||||||||||||
Derivative financial instruments | |||||||||||||||||||||||
IRLCs | 2023 | $ |
|
$ |
|
$ |
|
||||||||||||||||
LPCs | 2023 |
|
|
|
|||||||||||||||||||
Forward MBS trades | 2023 |
|
|
|
|||||||||||||||||||
Treasury futures | 2023 |
|
|
|
|||||||||||||||||||
Total derivative financial instruments - assets | $ |
|
$ |
|
$ |
|
|||||||||||||||||
Liabilities | |||||||||||||||||||||||
Derivative financial instruments | |||||||||||||||||||||||
IRLCs | 2023 | $ |
|
$ |
|
$ |
|
||||||||||||||||
LPCs | 2023 |
|
|
|
|||||||||||||||||||
Forward MBS trades | 2023 |
|
|
(
|
|||||||||||||||||||
Treasury futures | 2023 |
|
|
(
|
|||||||||||||||||||
Total derivative financial instruments - liabilities | $ |
|
$ |
|
$ |
(
|
September 30, 2022 | Nine Months Ended September 30, 2022 | ||||||||||||||||||||||
Derivative Financial Instruments |
Expiration
Dates |
Outstanding
Notional |
Fair
Value |
Gains/(Losses) | |||||||||||||||||||
Assets | |||||||||||||||||||||||
Mortgage loans held for sale | |||||||||||||||||||||||
Loan sale commitments | 2022 | $ |
|
$ |
(
|
$ |
(
|
||||||||||||||||
Derivative financial instruments | |||||||||||||||||||||||
IRLCs | 2022 | $ |
|
$ |
|
$ |
(
|
||||||||||||||||
LPCs | 2022 |
|
|
(
|
|||||||||||||||||||
Forward MBS trades | 2022 |
|
|
|
|||||||||||||||||||
Treasury futures | 2022 |
|
|
|
|||||||||||||||||||
Total derivative financial instruments - assets | $ |
|
$ |
|
$ |
|
|||||||||||||||||
Liabilities | |||||||||||||||||||||||
Derivative financial instruments | |||||||||||||||||||||||
IRLCs | 2022 | $ |
|
$ |
|
$ |
(
|
||||||||||||||||
LPCs | 2022 |
|
|
(
|
|||||||||||||||||||
Forward MBS trades | 2022 |
|
|
(
|
|||||||||||||||||||
Treasury futures | 2022 |
|
|
(
|
|||||||||||||||||||
Total derivative financial instruments - liabilities | $ |
|
$ |
|
$ |
(
|
September 30, 2023 | December 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||
Maturity Date | Collateral | Capacity Amount | Outstanding | Collateral Pledged | Outstanding | Collateral Pledged | ||||||||||||||||||||||||||||||||||||||
Advance Facilities | ||||||||||||||||||||||||||||||||||||||||||||
$350 advance facility | October 2024 | Servicing advance receivables | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||
$250 advance facility
(1)
|
November 2024 | Servicing advance receivables |
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||
$250 advance facility | January 2024 | Servicing advance receivables |
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||
$75 advance facility | December 2023 | Servicing advance receivables |
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||
Advance facilities principal amount |
|
|
|
|
||||||||||||||||||||||||||||||||||||||||
Warehouse Facilities | ||||||||||||||||||||||||||||||||||||||||||||
$1,500 warehouse facility | June 2024 | Mortgage loans or MBS |
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||
$750 warehouse facility | June 2024 | Mortgage loans or MBS |
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||
$750 warehouse facility | October 2024 | Mortgage loans or MBS |
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||
$500 warehouse facility | June 2024 | Mortgage loans or MBS |
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||
$500 warehouse facility
(2)
|
August 2024 | Mortgage loans or MBS |
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||
$300 warehouse facility | November 2023 | Mortgage loans or MBS |
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||
$250 warehouse facility
(3)
|
September 2025 | Mortgage loans or MBS |
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||
$200 warehouse facility | December 2024 | Mortgage loans or MBS |
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||
$200 warehouse facility | January 2024 | Mortgage loans or MBS |
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||
$100 warehouse facility | April 2024 | Mortgage loans or MBS |
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||
$100 warehouse facility | April 2024 | Mortgage loans or MBS |
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||
$75 warehouse facility | December 2023 | Mortgage loans or MBS |
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||
$1 warehouse facility | December 2023 | Mortgage loans or MBS |
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||
Warehouse facilities principal amount |
|
|
|
|
||||||||||||||||||||||||||||||||||||||||
MSR Facilities | ||||||||||||||||||||||||||||||||||||||||||||
$1,500 warehouse facility
(1)
|
November 2024 | MSR |
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||
$1,500 warehouse facility | April 2025 | MSR |
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||
$750 warehouse facility
(3)
|
September 2025 | MSR |
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||
$500 warehouse facility | June 2025 | MSR |
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||
$500 warehouse facility | April 2025 | MSR |
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||
$500 warehouse facility | June 2025 | MSR |
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||
$50 warehouse facility | November 2024 | MSR |
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||
MSR facilities principal amount |
|
|
|
|
||||||||||||||||||||||||||||||||||||||||
Advance, warehouse and MSR facilities principal amount |
|
|
|
|
||||||||||||||||||||||||||||||||||||||||
Unamortized debt issuance costs |
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||
Advance, warehouse and MSR facilities, net | $ |
|
$ |
|
Unsecured Senior Notes | September 30, 2023 | December 31, 2022 | |||||||||
$
|
$ |
|
$ |
|
|||||||
$
|
|
|
|||||||||
$
|
|
|
|||||||||
$
|
|
|
|||||||||
$
|
|
|
|||||||||
Unsecured senior notes principal amount |
|
|
|||||||||
Purchase discount
(1)
and unamortized debt issuance costs
|
(
|
(
|
|||||||||
Unsecured senior notes, net | $ |
|
$ |
|
Year Ending December 31, | Amount | |||||||
2023 through 2025 | $ |
|
||||||
2026 |
|
|||||||
2027 |
|
|||||||
Thereafter |
|
|||||||
Total unsecured senior notes principal amount | $ |
|
September 30, 2023 | December 31, 2022 | ||||||||||
Consolidated Transactions with VIEs |
Transfers
Accounted for as Secured Borrowings |
Transfers
Accounted for as Secured Borrowings |
|||||||||
Assets | |||||||||||
Restricted cash | $ |
|
$ |
|
|||||||
Advances and other receivables, net |
|
|
|||||||||
Total assets | $ |
|
$ |
|
|||||||
Liabilities | |||||||||||
Advance facilities, net
(1)
|
$ |
|
$ |
|
|||||||
Payables and other liabilities |
|
|
|||||||||
Total liabilities | $ |
|
$ |
|
Unconsolidated Securitization Trusts | September 30, 2023 | December 31, 2022 | |||||||||
Total collateral balances - UPB | $ |
|
$ |
|
|||||||
Total certificate balances | $ |
|
$ |
|
Principal Amount of Transferred Loans 60 Days or More Past Due | September 30, 2023 | December 31, 2022 | |||||||||
Unconsolidated securitization trusts | $ |
|
$ |
|
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
Computation of Earnings Per Share | 2023 | 2022 | 2023 | 2022 | |||||||||||||||||||
Net income | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Weighted average shares of common stock outstanding (in thousands): | |||||||||||||||||||||||
Basic |
|
|
|
|
|||||||||||||||||||
Dilutive effect of stock awards |
|
|
|
|
|||||||||||||||||||
Diluted |
|
|
|
|
|||||||||||||||||||
Earnings per common share | |||||||||||||||||||||||
Basic | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Diluted | $ |
|
$ |
|
$ |
|
$ |
|
September 30, 2023 | |||||||||||||||||||||||
Recurring Fair Value Measurements | |||||||||||||||||||||||
Fair Value - Recurring Basis | Total Fair Value | Level 1 | Level 2 | Level 3 | |||||||||||||||||||
Assets | |||||||||||||||||||||||
Mortgage loans held for sale | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Mortgage servicing rights |
|
|
|
|
|||||||||||||||||||
Equity investments |
|
|
|
|
|||||||||||||||||||
Derivative financial instruments | |||||||||||||||||||||||
IRLCs |
|
|
|
|
|||||||||||||||||||
LPCs |
|
|
|
|
|||||||||||||||||||
Forward MBS trades |
|
|
|
|
|||||||||||||||||||
Liabilities | |||||||||||||||||||||||
Derivative financial instruments | |||||||||||||||||||||||
LPCs |
|
|
|
|
|||||||||||||||||||
Forward MBS trades |
|
|
|
|
|||||||||||||||||||
Treasury futures |
|
|
|
|
|||||||||||||||||||
Mortgage servicing rights financing |
|
|
|
|
|||||||||||||||||||
Excess spread financing |
|
|
|
|
December 31, 2022 | ||||||||||||||||||||||||||
Recurring Fair Value Measurements | ||||||||||||||||||||||||||
Fair Value - Recurring Basis | Total Fair Value | Level 1 | Level 2 | Level 3 | ||||||||||||||||||||||
Assets | ||||||||||||||||||||||||||
Mortgage loans held for sale | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
Mortgage servicing rights |
|
|
|
|
||||||||||||||||||||||
Equity investments |
|
|
|
|
||||||||||||||||||||||
Derivative financial instruments | ||||||||||||||||||||||||||
IRLCs |
|
|
|
|
||||||||||||||||||||||
Forward MBS trades |
|
|
|
|
||||||||||||||||||||||
LPCs |
|
|
|
|
||||||||||||||||||||||
Liabilities | ||||||||||||||||||||||||||
Derivative financial instruments | ||||||||||||||||||||||||||
Forward MBS trades |
|
|
|
|
||||||||||||||||||||||
LPCs |
|
|
|
|
||||||||||||||||||||||
Treasury futures |
|
|
|
|
||||||||||||||||||||||
Mortgage servicing rights financing |
|
|
|
|
||||||||||||||||||||||
Excess spread financing |
|
|
|
|
Nine Months Ended September 30, 2023 | |||||||||||||||||||||||||||||||||||
Assets | Liabilities | ||||||||||||||||||||||||||||||||||
Fair Value - Level 3 Assets and Liabilities | Mortgage servicing rights | Mortgage loans held for sale | Equity investments | IRLCs | Excess spread financing | Mortgage servicing rights financing | |||||||||||||||||||||||||||||
Balance - beginning of period | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
Changes in fair value included in earnings |
(
|
|
(
|
|
(
|
|
|||||||||||||||||||||||||||||
Purchases/additions
(1)
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Issuances |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Sales/dispositions
(2)
|
(
|
(
|
|
|
|
|
|||||||||||||||||||||||||||||
Repayments |
|
(
|
|
|
(
|
|
|||||||||||||||||||||||||||||
Settlements |
|
|
|
|
(
|
|
|||||||||||||||||||||||||||||
Other changes |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
Balance - end of period | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
Nine Months Ended September 30, 2022 | |||||||||||||||||||||||||||||
Assets | Liabilities | ||||||||||||||||||||||||||||
Fair Value - Level 3 Assets and Liabilities | Mortgage servicing rights | Equity investments | IRLCs | Excess spread financing | Mortgage servicing rights financing | ||||||||||||||||||||||||
Balance - beginning of period | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
Changes in fair value included in earnings |
|
(
|
(
|
|
|
||||||||||||||||||||||||
Purchases |
|
|
|
|
|
||||||||||||||||||||||||
Issuances |
|
|
|
|
|
||||||||||||||||||||||||
Sales |
(
|
|
|
|
|
||||||||||||||||||||||||
Repayments |
|
|
|
(
|
|
||||||||||||||||||||||||
Settlements |
|
|
|
(
|
|
||||||||||||||||||||||||
Other changes |
|
|
|
|
|
||||||||||||||||||||||||
Balance - end of period | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
September 30, 2023 | December 31, 2022 | ||||||||||||||||||||||||||||||||||
Range | Weighted Average | Range | Weighted Average | ||||||||||||||||||||||||||||||||
Level 3 Inputs | Min | Max | Min | Max | |||||||||||||||||||||||||||||||
MSRs
(1)
|
|||||||||||||||||||||||||||||||||||
Option adjusted spread
(2)
|
|
% |
|
% |
|
% | N/A | N/A | N/A | ||||||||||||||||||||||||||
Discount rate | N/A | N/A | N/A |
|
% |
|
% |
|
% | ||||||||||||||||||||||||||
Prepayment speed |
|
% |
|
% |
|
% |
|
% |
|
% |
|
% | |||||||||||||||||||||||
Cost to service per loan
(3)
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
Average life
(4)
|
|
|
|||||||||||||||||||||||||||||||||
Mortgage loans held for sale | |||||||||||||||||||||||||||||||||||
Market pricing |
|
% |
|
% |
|
% |
|
% |
|
% |
|
% | |||||||||||||||||||||||
IRLCs | |||||||||||||||||||||||||||||||||||
Value of servicing (reflected as a percentage of loan commitment) |
|
% |
|
% |
|
% |
(
|
% |
|
% |
|
% | |||||||||||||||||||||||
Excess spread financing
(1)
|
|||||||||||||||||||||||||||||||||||
Option adjusted spread
(2)
|
|
% |
|
% |
|
% | N/A | N/A | N/A | ||||||||||||||||||||||||||
Discount rate | N/A | N/A | N/A |
|
% |
|
% |
|
% | ||||||||||||||||||||||||||
Prepayment speed |
|
% |
|
% |
|
% |
|
% |
|
% |
|
% | |||||||||||||||||||||||
Average life
(4)
|
|
|
|||||||||||||||||||||||||||||||||
Mortgage servicing rights financing | |||||||||||||||||||||||||||||||||||
Advance financing and counterparty fee rates |
|
% |
|
% |
|
% |
|
% |
|
% |
|
% | |||||||||||||||||||||||
Annual advance recovery rates |
|
% |
|
% |
|
% |
|
% |
|
% |
|
% |
September 30, 2023 | |||||||||||||||||||||||
Carrying
Amount |
Fair Value | ||||||||||||||||||||||
Financial Instruments | Level 1 | Level 2 | Level 3 | ||||||||||||||||||||
Financial assets | |||||||||||||||||||||||
Cash and cash equivalents | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Restricted cash |
|
|
|
|
|||||||||||||||||||
Advances and other receivables, net |
|
|
|
|
|||||||||||||||||||
Loans subject to repurchase from Ginnie Mae |
|
|
|
|
|||||||||||||||||||
Financial liabilities | |||||||||||||||||||||||
Unsecured senior notes, net |
|
|
|
|
|||||||||||||||||||
Advance, warehouse and MSR facilities, net |
|
|
|
|
|||||||||||||||||||
Liability for loans subject to repurchase from Ginnie Mae |
|
|
|
|
December 31, 2022 | |||||||||||||||||||||||
Carrying
Amount |
Fair Value | ||||||||||||||||||||||
Financial Instruments | Level 1 | Level 2 | Level 3 | ||||||||||||||||||||
Financial assets | |||||||||||||||||||||||
Cash and cash equivalents | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Restricted cash |
|
|
|
|
|||||||||||||||||||
Advances and other receivables, net |
|
|
|
|
|||||||||||||||||||
Loans subject to repurchase from Ginnie Mae |
|
|
|
|
|||||||||||||||||||
Financial liabilities | |||||||||||||||||||||||
Unsecured senior notes, net |
|
|
|
|
|||||||||||||||||||
Advance, warehouse and MSR facilities, net |
|
|
|
|
|||||||||||||||||||
Liability for loans subject to repurchase from Ginnie Mae |
|
|
|
|
Three Months Ended September 30, 2023 | |||||||||||||||||||||||
Financial Information by Segment | Servicing | Originations | Corporate/Other | Consolidated | |||||||||||||||||||
Revenues | |||||||||||||||||||||||
Service related, net | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Net gain on mortgage loans held for sale |
|
|
|
|
|||||||||||||||||||
Total revenues |
|
|
|
|
|||||||||||||||||||
Total expenses |
|
|
|
|
|||||||||||||||||||
Interest income |
|
|
|
|
|||||||||||||||||||
Interest expense |
(
|
(
|
(
|
(
|
|||||||||||||||||||
Other income, net |
|
|
|
|
|||||||||||||||||||
Total other income (expenses), net |
|
(
|
|
|
|||||||||||||||||||
Income (loss) before income tax expense | $ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||
Depreciation and amortization for property and equipment and intangible assets | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Total assets | $ |
|
$ |
|
$ |
|
$ |
|
Three Months Ended September 30, 2022 | |||||||||||||||||||||||
Financial Information by Segment | Servicing | Originations | Corporate/Other | Consolidated | |||||||||||||||||||
Revenues | |||||||||||||||||||||||
Service related, net | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Net (loss) gain on mortgage loans held for sale |
(
|
|
|
|
|||||||||||||||||||
Total revenues |
|
|
|
|
|||||||||||||||||||
Total expenses |
|
|
|
|
|||||||||||||||||||
Interest income |
|
|
|
|
|||||||||||||||||||
Interest expense |
(
|
(
|
(
|
(
|
|||||||||||||||||||
Other expense, net |
|
|
(
|
(
|
|||||||||||||||||||
Total other income (expenses), net |
|
|
(
|
(
|
|||||||||||||||||||
Income (loss) before income tax expense | $ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||
Depreciation and amortization for property and equipment and intangible assets | $ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||
Total assets | $ |
|
$ |
|
$ |
|
$ |
|
Nine Months Ended September 30, 2023 | |||||||||||||||||||||||
Financial Information by Segment | Servicing | Originations | Corporate/Other | Consolidated | |||||||||||||||||||
Revenues | |||||||||||||||||||||||
Service related, net | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Net gain on mortgage loans held for sale |
|
|
|
|
|||||||||||||||||||
Total revenues |
|
|
|
|
|||||||||||||||||||
Total expenses |
|
|
|
|
|||||||||||||||||||
Interest income |
|
|
|
|
|||||||||||||||||||
Interest expense |
(
|
(
|
(
|
(
|
|||||||||||||||||||
Other income, net |
|
|
|
|
|||||||||||||||||||
Total other income (expenses), net |
|
(
|
(
|
|
|||||||||||||||||||
Income (loss) before income tax expense | $ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||
Depreciation and amortization for property and equipment and intangible assets | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Total assets | $ |
|
$ |
|
$ |
|
$ |
|
Nine Months Ended September 30, 2022 | |||||||||||||||||||||||
Financial Information by Segment | Servicing | Originations | Corporate/Other | Consolidated | |||||||||||||||||||
Revenues | |||||||||||||||||||||||
Service related, net | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
Net (loss) gain on mortgage loans held for sale |
(
|
|
|
|
|||||||||||||||||||
Total revenues |
|
|
|
|
|||||||||||||||||||
Total expenses |
|
|
|
|
|||||||||||||||||||
Interest income |
|
|
|
|
|||||||||||||||||||
Interest expense |
(
|
(
|
(
|
(
|
|||||||||||||||||||
Other income, net |
|
|
|
|
|||||||||||||||||||
Total other (expenses) income, net |
(
|
|
|
|
|||||||||||||||||||
Income (loss) before income tax expense | $ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||
Depreciation and amortization for property and equipment and intangible assets | $ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||
Total assets | $ |
|
$ |
|
$ |
|
$ |
|
Overview |
Table 1. Consolidated Operations
|
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||||||||||||||
2023 | 2022 | Change | 2023 | 2022 | Change | ||||||||||||||||||||||||||||||
Revenues - operational
(1)
|
$ | 511 | $ | 386 | $ | 125 | $ | 1,325 | $ | 1,284 | $ | 41 | |||||||||||||||||||||||
Revenues - mark-to-market | 63 | 124 | (61) | 65 | 877 | (812) | |||||||||||||||||||||||||||||
Total revenues | 574 | 510 | 64 | 1,390 | 2,161 | (771) | |||||||||||||||||||||||||||||
Total expenses | 301 | 316 | (15) | 840 | 982 | (142) | |||||||||||||||||||||||||||||
Total other income (expense), net | 79 | (41) | 120 | 35 | 45 | (10) | |||||||||||||||||||||||||||||
Income before income tax expense | 352 | 153 | 199 | 585 | 1,224 | (639) | |||||||||||||||||||||||||||||
Less: Income tax expense | 77 | 40 | 37 | 131 | 302 | (171) | |||||||||||||||||||||||||||||
Net income | $ | 275 | $ | 113 | $ | 162 | $ | 454 | $ | 922 | $ | (468) |
Segment Results |
Servicing Segment |
Table 2. Servicer Ratings
|
Fitch
(1)
|
Moody’s
(2)
|
S&P
(3)
|
|||||||||||||||
Rating date | August 2022 | May 2023 | June 2022 | ||||||||||||||
Residential | RPS2 | SQ2- | Above Average | ||||||||||||||
Master Servicer | RMS2+ | SQ2+ | Above Average | ||||||||||||||
Special Servicer | RSS2 | SQ2- | Above Average | ||||||||||||||
Subprime Servicer | RPS2 | SQ2- | Above Average | ||||||||||||||
Rushmore Special
(4)
|
RSS1- | SQ3+ | Above Average |
Table 3. Servicing Segment Results of Operations
|
Three Months Ended September 30, | |||||||||||||||||||||||||||||||||||
2023 | 2022 | Change | |||||||||||||||||||||||||||||||||
Amt |
bps
(1)
|
Amt |
bps
(1)
|
Amt | bps | ||||||||||||||||||||||||||||||
Revenues | |||||||||||||||||||||||||||||||||||
Operational | $ | 561 | 25 | $ | 377 | 18 | $ | 184 | 7 | ||||||||||||||||||||||||||
Amortization, net of accretion | (160) | (7) | (169) | (8) | 9 | 1 | |||||||||||||||||||||||||||||
Mark-to-market adjustments - Servicing | 63 | 3 | 124 | 6 | (61) | (3) | |||||||||||||||||||||||||||||
Total revenues | 464 | 21 | 332 | 16 | 132 | 5 | |||||||||||||||||||||||||||||
Expenses | |||||||||||||||||||||||||||||||||||
Salaries, wages and benefits | 87 | 4 | 82 | 4 | 5 | — | |||||||||||||||||||||||||||||
General and administrative | |||||||||||||||||||||||||||||||||||
Servicing support fees | 29 | 1 | 21 | 1 | 8 | — | |||||||||||||||||||||||||||||
Corporate and other general and administrative expenses | 52 | 3 | 29 | 2 | 23 | 1 | |||||||||||||||||||||||||||||
Foreclosure and other liquidation related expenses (recoveries), net | — | — | 9 | — | (9) | — | |||||||||||||||||||||||||||||
Depreciation and amortization | 4 | — | 6 | — | (2) | — | |||||||||||||||||||||||||||||
Total general and administrative expenses | 85 | 4 | 65 | 3 | 20 | 1 | |||||||||||||||||||||||||||||
Total expenses | 172 | 8 | 147 | 7 | 25 | 1 | |||||||||||||||||||||||||||||
Other income (expense) | |||||||||||||||||||||||||||||||||||
Interest income | 157 | 7 | 71 | 3 | 86 | 4 | |||||||||||||||||||||||||||||
Advance interest expense | (13) | (1) | (8) | — | (5) | (1) | |||||||||||||||||||||||||||||
Other interest expense | (75) | (3) | (45) | (2) | (30) | (1) | |||||||||||||||||||||||||||||
Interest expense | (88) | (4) | (53) | (2) | (35) | (2) | |||||||||||||||||||||||||||||
Total other income, net | 69 | 3 | 18 | 1 | 51 | 2 | |||||||||||||||||||||||||||||
Income before income tax expense | $ | 361 | 16 | $ | 203 | 10 | $ | 158 | 6 | ||||||||||||||||||||||||||
Weighted average cost - advance and MSR facilities | 8.2 | % | 5.1 | % | 3.1 | % | |||||||||||||||||||||||||||||
Weighted average cost - excess spread financing | 8.7 | % | 8.7 | % | — | % |
Table 3.1 Servicing - Revenues
|
Three Months Ended September 30, | |||||||||||||||||||||||||||||||||||
2023 | 2022 | Change | |||||||||||||||||||||||||||||||||
Amt |
bps
(1)
|
Amt |
bps
(1)
|
Amt | bps | ||||||||||||||||||||||||||||||
MSR Operational Revenue | |||||||||||||||||||||||||||||||||||
Base servicing fees | $ | 382 | 17 | $ | 311 | 15 | $ | 71 | 2 | ||||||||||||||||||||||||||
Modification fees | 6 | — | 2 | — | 4 | — | |||||||||||||||||||||||||||||
Late payment fees | 17 | — | 15 | 1 | 2 | (1) | |||||||||||||||||||||||||||||
Other ancillary revenues | 82 | 4 | (4) | — | 86 | 4 | |||||||||||||||||||||||||||||
Total MSR operational revenue | 487 | 21 | 324 | 16 | 163 | 5 | |||||||||||||||||||||||||||||
Subservicing-related revenue | 92 | 4 | 71 | 3 | 21 | 1 | |||||||||||||||||||||||||||||
Total servicing fee revenue | 579 | 25 | 395 | 19 | 184 | 6 | |||||||||||||||||||||||||||||
MSR financing liability costs | (7) | — | (4) | — | (3) | — | |||||||||||||||||||||||||||||
Excess spread payments and portfolio runoff | (11) | — | (14) | (1) | 3 | 1 | |||||||||||||||||||||||||||||
Total operational revenue | 561 | 25 | 377 | 18 | 184 | 7 | |||||||||||||||||||||||||||||
Amortization, Net of Accretion | |||||||||||||||||||||||||||||||||||
MSR amortization | (171) | (7) | (183) | (9) | 12 | 2 | |||||||||||||||||||||||||||||
Excess spread accretion | 11 | — | 14 | 1 | (3) | (1) | |||||||||||||||||||||||||||||
Total amortization, net of accretion | (160) | (7) | (169) | (8) | 9 | 1 | |||||||||||||||||||||||||||||
Mark-to-Market Adjustments - Servicing | |||||||||||||||||||||||||||||||||||
MSR MTM | 270 | 12 | 239 | 12 | 31 | — | |||||||||||||||||||||||||||||
Loss on MSR hedging activities | (192) | (9) | (100) | (5) | (92) | (4) | |||||||||||||||||||||||||||||
Loss on MSR sales | (3) | — | (2) | — | (1) | — | |||||||||||||||||||||||||||||
Reclassifications
(2)
|
(8) | — | (10) | (1) | 2 | 1 | |||||||||||||||||||||||||||||
Excess spread / MSR financing MTM | (4) | — | (3) | — | (1) | — | |||||||||||||||||||||||||||||
Total mark-to-market adjustments - Servicing | 63 | 3 | 124 | 6 | (61) | (3) | |||||||||||||||||||||||||||||
Total revenues - Servicing | $ | 464 | 21 | $ | 332 | 16 | $ | 132 | 5 |
Table 4. Servicing Segment Results of Operations
|
Nine Months Ended September 30, | |||||||||||||||||||||||||||||||||||
2023 | 2022 | Change | |||||||||||||||||||||||||||||||||
Amt |
bps
(1)
|
Amt |
bps
(1)
|
Amt | bps | ||||||||||||||||||||||||||||||
Revenues | |||||||||||||||||||||||||||||||||||
Operational | $ | 1,410 | 22 | $ | 1,136 | 19 | $ | 274 | 3 | ||||||||||||||||||||||||||
Amortization, net of accretion | (412) | (7) | (570) | (10) | 158 | 3 | |||||||||||||||||||||||||||||
Mark-to-market adjustments - Servicing | 65 | 1 | 877 | 15 | (812) | (14) | |||||||||||||||||||||||||||||
Total revenues | 1,063 | 16 | 1,443 | 24 | (380) | (8) | |||||||||||||||||||||||||||||
Expenses | |||||||||||||||||||||||||||||||||||
Salaries, wages and benefits | 252 | 4 | 241 | 4 | 11 | — | |||||||||||||||||||||||||||||
General and administrative | |||||||||||||||||||||||||||||||||||
Servicing support fees | 66 | 1 | 56 | 1 | 10 | — | |||||||||||||||||||||||||||||
Corporate and other general and administrative expenses | 138 | 2 | 86 | 2 | 52 | — | |||||||||||||||||||||||||||||
Foreclosure and other liquidation related expenses, net | 19 | — | 13 | — | 6 | — | |||||||||||||||||||||||||||||
Depreciation and amortization | 9 | — | 16 | — | (7) | — | |||||||||||||||||||||||||||||
Total general and administrative expenses | 232 | 3 | 171 | 3 | 61 | — | |||||||||||||||||||||||||||||
Total expenses | 484 | 7 | 412 | 7 | 72 | — | |||||||||||||||||||||||||||||
Other income (expense) | |||||||||||||||||||||||||||||||||||
Interest income | 343 | 5 | 125 | 2 | 218 | 3 | |||||||||||||||||||||||||||||
Advance interest expense | (41) | — | (22) | — | (19) | — | |||||||||||||||||||||||||||||
Other interest expense | (183) | (3) | (146) | (2) | (37) | (1) | |||||||||||||||||||||||||||||
Interest expense | (224) | (3) | (168) | (2) | (56) | (1) | |||||||||||||||||||||||||||||
Total other income (expense), net | 119 | 2 | (43) | — | 162 | 2 | |||||||||||||||||||||||||||||
Income before income tax expense | $ | 698 | 11 | $ | 988 | 17 | $ | (290) | (6) | ||||||||||||||||||||||||||
Weighted average cost - advance and MSR facilities | 7.8 | % | 3.9 | % | 3.9 | % | |||||||||||||||||||||||||||||
Weighted average cost - excess spread financing | 8.7 | % | 8.8 | % | (0.1) | % |
Table 4.1 Servicing - Revenues
|
||
Nine Months Ended September 30, | |||||||||||||||||||||||||||||||||||
2023 | 2022 | Change | |||||||||||||||||||||||||||||||||
Amt |
bps
(1)
|
Amt |
bps
(1)
|
Amt | bps | ||||||||||||||||||||||||||||||
MSR Operational Revenue | |||||||||||||||||||||||||||||||||||
Base servicing fees | $ | 1,054 | 16 | $ | 907 | 15 | $ | 147 | 1 | ||||||||||||||||||||||||||
Modification fees | 14 | — | 11 | — | 3 | — | |||||||||||||||||||||||||||||
Late payment fees | 49 | 1 | 45 | 1 | 4 | — | |||||||||||||||||||||||||||||
Other ancillary revenues | 107 | 2 | 53 | 1 | 54 | 1 | |||||||||||||||||||||||||||||
Total MSR operational revenue | 1,224 | 19 | 1,016 | 17 | 208 | 2 | |||||||||||||||||||||||||||||
Subservicing-related revenue | 240 | 3 | 208 | 3 | 32 | — | |||||||||||||||||||||||||||||
Total servicing fee revenue | 1,464 | 22 | 1,224 | 20 | 240 | 2 | |||||||||||||||||||||||||||||
MSR financing liability costs | (22) | — | (14) | — | (8) | — | |||||||||||||||||||||||||||||
Excess spread payments and portfolio runoff | (32) | — | (74) | (1) | 42 | 1 | |||||||||||||||||||||||||||||
Total operational revenue | 1,410 | 22 | 1,136 | 19 | 274 | 3 | |||||||||||||||||||||||||||||
Amortization, Net of Accretion | |||||||||||||||||||||||||||||||||||
MSR amortization | (444) | (7) | (644) | (11) | 200 | 4 | |||||||||||||||||||||||||||||
Excess spread accretion | 32 | — | 74 | 1 | (42) | (1) | |||||||||||||||||||||||||||||
Total amortization, net of accretion | (412) | (7) | (570) | (10) | 158 | 3 | |||||||||||||||||||||||||||||
Mark-to-Market Adjustments - Servicing | |||||||||||||||||||||||||||||||||||
MSR MTM | 304 | 5 | 1,363 | 23 | (1,059) | (18) | |||||||||||||||||||||||||||||
Loss on MSR hedging activities | (244) | (4) | (329) | (6) | 85 | 2 | |||||||||||||||||||||||||||||
Gain (loss) on MSR sales | 29 | — | (1) | — | 30 | — | |||||||||||||||||||||||||||||
Reclassifications
(2)
|
(26) | — | (22) | — | (4) | — | |||||||||||||||||||||||||||||
Excess spread / MSR financing MTM | 2 | — | (134) | (2) | 136 | 2 | |||||||||||||||||||||||||||||
Total mark-to-market adjustments - Servicing | 65 | 1 | 877 | 15 | (812) | (14) | |||||||||||||||||||||||||||||
Total revenues - Servicing | $ | 1,063 | 16 | $ | 1,443 | 24 | $ | (380) | (8) |
Table 5. Servicing Portfolio - Unpaid Principal Balances
|
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||||||||||||||
Average UPB | ||||||||||||||||||||||||||||||||||||||
MSRs | $ | 500,825 | $ | 394,703 | $ | 449,602 | $ | 376,551 | ||||||||||||||||||||||||||||||
Subservicing and other
(1)
|
396,673 | 428,423 | 418,942 | 412,925 | ||||||||||||||||||||||||||||||||||
Total average UPB | $ | 897,498 | $ | 823,126 | $ | 868,544 | $ | 789,476 | ||||||||||||||||||||||||||||||
September 30, 2023 | September 30, 2022 | |||||||||||||||||||||||||||||||||||||
UPB | Carrying Amount | bps | UPB | Carrying Amount | bps | |||||||||||||||||||||||||||||||||
MSRs | ||||||||||||||||||||||||||||||||||||||
Agency | $ | 501,315 | $ | 8,193 | 163 | $ | 363,637 | $ | 6,068 | 167 | ||||||||||||||||||||||||||||
Non-agency | 27,009 | 311 | 115 | 31,769 | 340 | 107 | ||||||||||||||||||||||||||||||||
Total MSRs | 528,324 | 8,504 | 161 | 395,406 | 6,408 | 162 | ||||||||||||||||||||||||||||||||
Subservicing and other
(1)
|
||||||||||||||||||||||||||||||||||||||
Agency | 360,565 | N/A | 434,396 | N/A | ||||||||||||||||||||||||||||||||||
Non-agency | 48,365 | N/A | 23,884 | N/A | ||||||||||||||||||||||||||||||||||
Total subservicing and other | 408,930 | N/A | 458,280 | N/A | ||||||||||||||||||||||||||||||||||
Total ending balance | $ | 937,254 | $ | 8,504 | $ | 853,686 | $ | 6,408 | ||||||||||||||||||||||||||||||
MSRs UPB Encumbrance | September 30, 2023 | September 30, 2022 | ||||||||||||||||||||||||||||||||||||
MSRs - unencumbered | $ | 451,567 | $ | 309,301 | ||||||||||||||||||||||||||||||||||
MSRs - encumbered
(2)
|
76,757 | 86,105 | ||||||||||||||||||||||||||||||||||||
MSRs UPB | $ | 528,324 | $ | 395,406 |
Table 6. Servicing and Subservicing and Other Portfolio UPB Rollforward
|
Three Months Ended September 30, 2023 | Three Months Ended September 30, 2022 | ||||||||||||||||||||||||||||||||||
MSR | Subservicing and Other | Total | MSR | Subservicing and Other | Total | ||||||||||||||||||||||||||||||
Balance - beginning of period | $ | 459,476 | $ | 422,522 | $ | 881,998 | $ | 397,387 | $ | 406,231 | $ | 803,618 | |||||||||||||||||||||||
Additions: | |||||||||||||||||||||||||||||||||||
Originations | 3,419 | — | 3,419 | 5,727 | — | 5,727 | |||||||||||||||||||||||||||||
Acquisitions / Increase in subservicing
(1)
|
98,563 | 19,494 | 118,057 | 6,098 | 65,419 | 71,517 | |||||||||||||||||||||||||||||
Deductions: | |||||||||||||||||||||||||||||||||||
Dispositions / Decrease in subservicing
(2)
|
(22,184) | (26,029) | (48,213) | (671) | (2,595) | (3,266) | |||||||||||||||||||||||||||||
Principal reductions and other | (4,469) | (2,838) | (7,307) | (4,374) | (3,046) | (7,420) | |||||||||||||||||||||||||||||
Voluntary reductions
(3)
|
(6,100) | (4,017) | (10,117) | (8,666) | (7,723) | (16,389) | |||||||||||||||||||||||||||||
Involuntary reductions
(4)
|
(353) | (202) | (555) | (100) | (6) | (106) | |||||||||||||||||||||||||||||
Net changes in loans serviced by others | (28) | — | (28) | 5 | — | 5 | |||||||||||||||||||||||||||||
Balance - end of period | $ | 528,324 | $ | 408,930 | $ | 937,254 | $ | 395,406 | $ | 458,280 | $ | 853,686 |
Table 6.1 Servicing and Subservicing and Other Portfolio UPB Rollforward
|
Nine Months Ended September 30, 2023 | Nine Months Ended September 30, 2022 | ||||||||||||||||||||||||||||||||||
MSR | Subservicing and Other | Total | MSR | Subservicing and Other | Total | ||||||||||||||||||||||||||||||
Balance - beginning of period | $ | 411,382 | $ | 459,053 | $ | 870,435 | $ | 339,208 | $ | 370,520 | $ | 709,728 | |||||||||||||||||||||||
Additions: | |||||||||||||||||||||||||||||||||||
Originations | 9,946 | — | 9,946 | 24,131 | — | 24,131 | |||||||||||||||||||||||||||||
Acquisitions / Increase in subservicing
(1)
|
160,756 | 89,558 | 250,314 | 98,414 | 159,643 | 258,057 | |||||||||||||||||||||||||||||
Deductions: | |||||||||||||||||||||||||||||||||||
Dispositions / Decrease in subservicing
(2)
|
(23,789) | (116,362) | (140,151) | (20,723) | (28,801) | (49,524) | |||||||||||||||||||||||||||||
Principal reductions and other | (12,740) | (10,116) | (22,856) | (11,760) | (9,934) | (21,694) | |||||||||||||||||||||||||||||
Voluntary reductions
(3)
|
(16,057) | (12,592) | (28,649) | (33,390) | (33,103) | (66,493) | |||||||||||||||||||||||||||||
Involuntary reductions
(4)
|
(1,071) | (611) | (1,682) | (317) | (45) | (362) | |||||||||||||||||||||||||||||
Net changes in loans serviced by others | (103) | — | (103) | (157) | — | (157) | |||||||||||||||||||||||||||||
Balance - end of period | $ | 528,324 | $ | 408,930 | $ | 937,254 | $ | 395,406 | $ | 458,280 | $ | 853,686 |
Table 7. Key Performance Metrics - Servicing and Subservicing Portfolio
|
September 30, 2023 | September 30, 2022 | |||||||||||||||||||||||||
Loan count | 4,288,683 | 4,086,628 | ||||||||||||||||||||||||
Average loan amount
(1)
|
$ | 218,561 | $ | 208,815 | ||||||||||||||||||||||
Average coupon - agency | 3.8 | % | 3.6 | % | ||||||||||||||||||||||
Average coupon - non-agency | 4.9 | % | 4.4 | % | ||||||||||||||||||||||
60+ delinquent (% of loans)
(2)
|
1.9 | % | 2.5 | % | ||||||||||||||||||||||
90+ delinquent (% of loans)
(2)
|
1.6 | % | 2.2 | % | ||||||||||||||||||||||
120+ delinquent (% of loans)
(2)
|
1.5 | % | 2.0 | % | ||||||||||||||||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||||||||||||
Total prepayment speed (12-month constant prepayment rate) | 5.3 | % | 8.3 | % | 5.0 | % | 11.3 | % |
Table 8. MSRs Loan Modifications and Workout Units
|
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||||||||||||||||||||||||||||||||
2023 | 2022 | Change | 2023 | 2022 | Change | ||||||||||||||||||||||||||||||||||||||||||||||||
Modifications
(1)
|
7,127 | 6,786 | 341 | 18,315 | 37,102 | (18,787) | |||||||||||||||||||||||||||||||||||||||||||||||
Workouts
(2)
|
14,332 | 9,719 | 4,613 | 36,348 | 37,622 | (1,274) | |||||||||||||||||||||||||||||||||||||||||||||||
Total modifications and workout units | 21,459 | 16,505 | 4,954 | 54,663 | 74,724 | (20,061) |
Table 9. MSRs - Fair Value Rollforward
|
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
Fair value - beginning of period | $ | 7,149 | $ | 6,151 | $ | 6,654 | $ | 4,223 | |||||||||||||||
Additions: | |||||||||||||||||||||||
Servicing retained from mortgage loans sold | 86 | 120 | 219 | 481 | |||||||||||||||||||
Purchases and acquisitions of servicing rights | 1,435 | 79 | 2,305 | 1,256 | |||||||||||||||||||
Dispositions: | |||||||||||||||||||||||
Sales of servicing assets and excess yield | (275) | (4) | (555) | (293) | |||||||||||||||||||
Changes in fair value: | |||||||||||||||||||||||
Due to changes in valuation inputs or assumptions used in the valuation model (MSR MTM): | |||||||||||||||||||||||
Agency | 255 | 234 | 310 | 1,348 | |||||||||||||||||||
Non-agency | 15 | 5 | (6) | 15 | |||||||||||||||||||
Changes in valuation due to amortization: | |||||||||||||||||||||||
Scheduled principal payments | (64) | (43) | (174) | (132) | |||||||||||||||||||
Prepayments | |||||||||||||||||||||||
Voluntary prepayments | |||||||||||||||||||||||
Agency | (97) | (131) | (245) | (475) | |||||||||||||||||||
Non-agency | (4) | (8) | (9) | (33) | |||||||||||||||||||
Involuntary prepayments | |||||||||||||||||||||||
Agency | (5) | (1) | (15) | (4) | |||||||||||||||||||
Non-agency | (1) | — | (1) | — | |||||||||||||||||||
Other changes
(1)
|
10 | 6 | 21 | 22 | |||||||||||||||||||
Fair value - end of period | $ | 8,504 | $ | 6,408 | $ | 8,504 | $ | 6,408 |
Table 10. Excess Spread Financing - Rollforward
|
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
Fair value - beginning of period | $ | 459 | $ | 532 | $ | 509 | $ | 768 | |||||||||||||||
Additions: | |||||||||||||||||||||||
New financings | — | — | — | — | |||||||||||||||||||
Deductions: | |||||||||||||||||||||||
Repayments | (1) | (1) | (5) | (293) | |||||||||||||||||||
Settlements | (18) | (19) | (54) | (80) | |||||||||||||||||||
Changes in fair value: | |||||||||||||||||||||||
Agency | 7 | 4 | (1) | 109 | |||||||||||||||||||
Non-agency | (1) | 3 | (3) | 15 | |||||||||||||||||||
Fair value - end of period | $ | 446 | $ | 519 | $ | 446 | $ | 519 |
Originations Segment |
Table 11. Originations Segment Results of Operations
|
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||||||||||||||
2023 | 2022 | Change | 2023 | 2022 | Change | ||||||||||||||||||||||||||||||
Revenues | |||||||||||||||||||||||||||||||||||
Service related, net - Originations
(1)
|
$ | 18 | $ | 20 | $ | (2) | $ | 45 | $ | 86 | $ | (41) | |||||||||||||||||||||||
Net gain on mortgage loans held for sale | |||||||||||||||||||||||||||||||||||
Net (loss) gain on loans originated and sold
(2)
|
(8) | 22 | (30) | 16 | 151 | (135) | |||||||||||||||||||||||||||||
Capitalized servicing rights
(3)
|
78 | 114 | (36) | 204 | 425 | (221) | |||||||||||||||||||||||||||||
Total net gain on mortgage loans held for sale | 70 | 136 | (66) | 220 | 576 | (356) | |||||||||||||||||||||||||||||
Total revenues | 88 | 156 | (68) | 265 | 662 | (397) | |||||||||||||||||||||||||||||
Expenses | |||||||||||||||||||||||||||||||||||
Salaries, wages and benefits | 37 | 68 | (31) | 107 | 275 | (168) | |||||||||||||||||||||||||||||
General and administrative | |||||||||||||||||||||||||||||||||||
Loan origination expenses | 7 | 15 | (8) | 23 | 50 | (27) | |||||||||||||||||||||||||||||
Corporate and other general administrative expenses | 7 | 12 | (5) | 24 | 43 | (19) | |||||||||||||||||||||||||||||
Marketing and professional service fees | 5 | 11 | (6) | 13 | 28 | (15) | |||||||||||||||||||||||||||||
Depreciation and amortization | 2 | 5 | (3) | 6 | 14 | (8) | |||||||||||||||||||||||||||||
Total general and administrative | 21 | 43 | (22) | 66 | 135 | (69) | |||||||||||||||||||||||||||||
Total expenses | 58 | 111 | (53) | 173 | 410 | (237) | |||||||||||||||||||||||||||||
Other income (expenses) | |||||||||||||||||||||||||||||||||||
Interest income | 10 | 12 | (2) | 26 | 44 | (18) | |||||||||||||||||||||||||||||
Interest expense | (11) | (11) | — | (28) | (33) | 5 | |||||||||||||||||||||||||||||
Total other (expenses) income, net | (1) | 1 | (2) | (2) | 11 | (13) | |||||||||||||||||||||||||||||
Income before income tax expense | $ | 29 | $ | 46 | $ | (17) | $ | 90 | $ | 263 | $ | (173) | |||||||||||||||||||||||
Weighted average note rate - mortgage loans held for sale | 6.8 | % | 5.1 | % | 1.7 | % | 6.4 | % | 4.0 | % | 2.4 | % | |||||||||||||||||||||||
Weighted average cost of funds - warehouse facilities (excluding facility fees) | 6.9 | % | 4.2 | % | 2.7 | % | 6.6 | % | 2.9 | % | 3.7 | % |
Table 12. Originations - Key Metrics
|
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||||||||||||||
2023 | 2022 | Change | 2023 | 2022 | Change | ||||||||||||||||||||||||||||||
Key Metrics | |||||||||||||||||||||||||||||||||||
Consumer direct lock pull through adjusted volume
(1)
|
$ | 1,578 | $ | 3,179 | $ | (1,601) | $ | 4,627 | $ | 13,409 | $ | (8,782) | |||||||||||||||||||||||
Other locked pull through adjusted volume
(1)
|
1,730 | 2,097 | (367) | 5,545 | 8,684 | (3,139) | |||||||||||||||||||||||||||||
Total pull through adjusted lock volume | $ | 3,308 | $ | 5,276 | $ | (1,968) | $ | 10,172 | $ | 22,093 | $ | (11,921) | |||||||||||||||||||||||
Funded volume
(2)
|
$ | 3,412 | $ | 5,741 | $ | (2,329) | $ | 9,973 | $ | 25,081 | $ | (15,108) | |||||||||||||||||||||||
Volume of loans sold | $ | 3,984 | $ | 6,387 | $ | (2,403) | $ | 10,776 | $ | 29,477 | $ | (18,701) | |||||||||||||||||||||||
Recapture percentage
(3)
|
24.2% | 28.4% | (4.2)% | 24.4% | 32.9% | (8.5)% | |||||||||||||||||||||||||||||
Refinance recapture percentage
(4)
|
82.7% | 79.6% | 3.1% | 77.9% | 56.2% | 21.7% | |||||||||||||||||||||||||||||
Purchase as a percentage of funded volume | 54.0% | 42.3% | 11.7% | 55.9% | 31.6% | 24.3% | |||||||||||||||||||||||||||||
Value of capitalized servicing on retained settlements | 225 bps | 221 bps | 4 bps | 222 bps | 188 bps | 34 bps | |||||||||||||||||||||||||||||
Originations Margin | |||||||||||||||||||||||||||||||||||
Revenue | $ | 88 | $ | 156 | $ | (68) | $ | 265 | $ | 662 | $ | (397) | |||||||||||||||||||||||
Pull through adjusted lock volume | $ | 3,308 | $ | 5,276 | $ | (1,968) | $ | 10,172 | $ | 22,093 | $ | (11,921) | |||||||||||||||||||||||
Revenue as a percentage of pull through adjusted lock volume
(5)
|
2.66 | % | 2.96 | % | (0.30) | % | 2.61 | % | 3.00 | % | (0.39) | % | |||||||||||||||||||||||
Expenses
(6)
|
$ | 59 | $ | 110 | $ | (51) | $ | 175 | $ | 399 | $ | (224) | |||||||||||||||||||||||
Funded volume | $ | 3,412 | $ | 5,741 | $ | (2,329) | $ | 9,973 | $ | 25,081 | $ | (15,108) | |||||||||||||||||||||||
Expenses as a percentage of funded volume
(7)
|
1.73 | % | 1.92% | (0.19) | % | 1.75 | % | 1.59% | 0.16 | % | |||||||||||||||||||||||||
Originations Margin | 0.93 | % | 1.04 | % | (0.11) | % | 0.86 | % | 1.41 | % | (0.55) | % |
Corporate/Other |
Table 13. Corporate/Other Selected Financial Results
|
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||||||||||||||||||||||||||||||||
2023 | 2022 | Change | 2023 | 2022 | Change | ||||||||||||||||||||||||||||||||||||||||||||||||
Corporate/Other - Operations | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Total revenues | $ | 22 | $ | 22 | $ | — | $ | 62 | $ | 56 | $ | 6 | |||||||||||||||||||||||||||||||||||||||||
Total expenses | 71 | 58 | 13 | 183 | 160 | 23 | |||||||||||||||||||||||||||||||||||||||||||||||
Interest expense | 47 | 40 | 7 | 126 | 120 | 6 | |||||||||||||||||||||||||||||||||||||||||||||||
Other income (expense), net | 58 | (20) | 78 | 44 | 197 | (153) | |||||||||||||||||||||||||||||||||||||||||||||||
Key Metrics | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Average exchange inventory under management | 27,384 | 21,680 | 5,704 | 26,658 | 18,435 | 8,223 |
Liquidity and Capital Resources
|
Table 14. Cash Flows
|
Nine Months Ended September 30, | |||||||||||||||||
2023 | 2022 | Change | |||||||||||||||
Net cash attributable to: | |||||||||||||||||
Operating activities | $ | 772 | $ | 3,144 | $ | (2,372) | |||||||||||
Investing activities | (1,088) | (987) | (101) | ||||||||||||||
Financing activities
|
318 | (2,520) | 2,838 | ||||||||||||||
Net increase (decrease) in cash, cash equivalents, and restricted cash
|
$ | 2 | $ | (363) | $ | 365 |
Table 15. Debt
|
September 30, 2023 | December 31, 2022 | ||||||||||
Advance facilities principal amount | $ | 548 | $ | 669 | |||||||
Warehouse facilities principal amount | 817 | 817 | |||||||||
MSR facilities principal amount | 2,195 | 1,410 | |||||||||
Unsecured senior notes principal amount | 3,200 | 2,700 |
Critical Accounting Policies and Estimates |
Other Matters |
Table 16. Change in Fair Value
|
September 30, 2023 | |||||||||||
Down 25 bps | Up 25 bps | ||||||||||
Increase (decrease) in assets | |||||||||||
Mortgage servicing rights at fair value | $ | (72) | $ | 64 | |||||||
Mortgage loans held for sale at fair value | 4 | (4) | |||||||||
Derivative financial instruments: | |||||||||||
Interest rate lock commitments | 5 | (5) | |||||||||
Forward MBS trades | (8) | 12 | |||||||||
Total change in assets | (71) | 67 | |||||||||
Increase (decrease) in liabilities | |||||||||||
Mortgage servicing rights financing at fair value | (2) | 1 | |||||||||
Excess spread financing at fair value | (2) | 2 | |||||||||
Derivative financial instruments: | |||||||||||
Interest rate lock commitments | (2) | 3 | |||||||||
Forward MBS trades | (12) | 15 | |||||||||
Treasury futures | (44) | 43 | |||||||||
Total change in liabilities | (62) | 64 | |||||||||
Total, net change | $ | (9) | $ | 3 |
Period |
(a) Total Number of Shares (or Units) Purchased
(in thousands) |
(b) Average Price Paid per Share (or Unit) |
(c) Total Number of Shares (or Units) Purchased as Part of Publicly Announced Plans or Programs
(in thousands) |
(d) Maximum Number (or Appropriate Dollar Value) of Shares (or Units) that May Yet Be Purchased Under the Plans or Program (in millions) | ||||||||||||||||||||||
July 2023 | 219 | $ | 55.99 | 219 | $ | 255 | ||||||||||||||||||||
August 2023 | 425 | $ | 57.13 | 425 | $ | 231 | ||||||||||||||||||||
September 2023 | 395 | $ | 54.33 | 395 | $ | 209 | ||||||||||||||||||||
Total | 1,039 | 1,039 |
Incorporated by Reference | ||||||||||||||||||||
Exhibit
Number |
Description | Form | File No. | Exhibit | Filing Date | Filed or Furnished Herewith | ||||||||||||||
4.1 | 8-K | 001-14667 | 4.1 | 08/01/2023 | ||||||||||||||||
4.2 | 8-K | 001-14667 | 4.2 | 08/01/2023 | ||||||||||||||||
4.3 | 8-K | 001-14667 | 4.3 | 08/01/2023 | ||||||||||||||||
4.4 | 8-K | 001-14667 | 4.4 | 08/01/2023 | ||||||||||||||||
4.5 | 8-K | 001-14667 | 4.5 | 08/01/2023 | ||||||||||||||||
4.6 | 8-K | 001-14667 | 4.6 | 08/01/2023 |
Incorporated by Reference | ||||||||||||||||||||
Exhibit
Number |
Description | Form | File No. | Exhibit | Filing Date | Filed or Furnished Herewith | ||||||||||||||
10.1 | X | |||||||||||||||||||
10.2** | X | |||||||||||||||||||
10.3** | X | |||||||||||||||||||
10.4** | X | |||||||||||||||||||
31.1 | X | |||||||||||||||||||
31.2 | X | |||||||||||||||||||
32.1 | X | |||||||||||||||||||
32.2 | X | |||||||||||||||||||
101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | X | ||||||||||||||||||
101.SCH | Inline XBRL Taxonomy Extension Schema Document | X | ||||||||||||||||||
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | X | ||||||||||||||||||
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | X | ||||||||||||||||||
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | X | ||||||||||||||||||
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | X | ||||||||||||||||||
104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibits 101.) | X |
MR. COOPER GROUP INC. | ||||||||
October 25, 2023 | /s/ Jay Bray | |||||||
Date |
Jay Bray
Chief Executive Officer (Principal Executive Officer) |
|||||||
October 25, 2023 | /s/ Kurt Johnson | |||||||
Date |
Kurt Johnson
Executive Vice President & Chief Financial Officer (Principal Financial and Accounting Officer) |
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|---|---|---|
Richelle P. Parham has served as a director of the Company since February 2016 and Chair of the Compensation and Human Capital Committee since June 2023. Ms. Parham currently serves as the President of Global E-Commerce and Business Development for Universal Music Group, a music-based entertainment company, a position she has held since June 2021. Prior to Universal Music Group, Ms. Parham served as a Managing Director of WestRiver Group, which is a collaboration of leading investment firms that provides integrated capital solutions to the global innovation economy with investments focused on technology, life sciences, energy, and experiential sectors from October 2019 to May 2021. She is also currently a Strategic Advisor at Camden Partners, a private equity firm, where she previously served as a General Partner from October 2016 to October 2019. Prior to Camden Partners, Ms. Parham served as Vice President, Chief Marketing Officer of eBay from November 2010 to March 2015. Ms. Parham was responsible, globally, for eBay brand strategy and brand marketing, to reach over 108+ million active eBay users, Internet marketing and for customer relationship management. Prior to joining eBay, Ms. Parham served as head of Global Marketing Innovation and Initiatives and head of Global Marketing Services at Visa, Inc. from 2008 to 2010. Ms. Parham founded and serves as Executive Chairman of the Board of Directors for Shyn, an oral care product company since January 2018. Her experience also includes 13 years at Digitas, Inc., a leading marketing agency, where she held a variety of senior leadership roles, including senior vice president and general manager of the agency’s Chicago office. Ms. Parham holds Bachelor of Science degrees in Business Administration and Design Arts from Drexel University. | |||
Peter M. Neupert has served as a director of the Company since January 2013. Mr. Neupert was an Operating Partner at Health Evolution Partners, a health only, middle market private equity firm, from January 2012 until June 2015. Prior to that, Mr. Neupert served as Corporate Vice President of the Microsoft Health Solutions Group from its formation in 2005 to January 2012. In addition, Mr. Neupert was a member of the Institute of Medicine’s Roundtable on Value & Science-Driven Healthcare from 2007 to 2012, a workshop dedicated to transforming the way evidence on clinical effectiveness is generated and used to improve health and healthcare. Mr. Neupert also served on the U.S. President’s Information Technology Advisory Committee, co-chairing the Health Information Technology Subcommittee and helping to drive the “Revolutionizing Health Care Through Information Technology” report, published in June 2004. Mr. Neupert served as the founding President and Chief Executive Officer of drugstore.com from 1998 to 2001 and as Chairman of the board of directors through September 2004. Mr. Neupert holds a Master of Business Administration from the Tuck School of Business at Dartmouth College and a Bachelor of Arts in Philosophy from Colorado College. | |||
Paul B. Rothman has served as a director of the Company and member of the Quality and Compliance Committee since June 2023. He has served as the Chair of the Quality and Compliance Committee since June 2024. Dr. Rothman, a rheumatologist and molecular immunologist, was previously the Dean of the Medical Faculty for Johns Hopkins University School of Medicine and CEO of Johns Hopkins Medicine, during which time he oversaw both the Johns Hopkins Health System and the School of Medicine. Prior to serving at Johns Hopkins, Dr. Rothman held various leadership positions at Columbia University and the University of Iowa. Dr. Rothman holds a Bachelor of Science in Biology from the Massachusetts Institute of Technology and a Doctor of Medicine from Yale University. | |||
Professional Highlights Richelle P. Parham has served as a director of the Company since February 2016 and Chair of the Compensation and Human Capital Committee since June 2023. Ms. Parham currently serves as the President of Global E-Commerce and Business Development for Universal Music Group, a music-based entertainment company, a position she has held since June 2021. Prior to Universal Music Group, Ms. Parham served as a Managing Director of WestRiver Group, which is a collaboration of leading investment firms that provides integrated capital solutions to the global innovation economy with investments focused on technology, life sciences, energy, and experiential sectors from October 2019 to May 2021. She is also currently a Strategic Advisor at Camden Partners, a private equity firm, where she previously served as a General Partner from October 2016 to October 2019. Prior to Camden Partners, Ms. Parham served as Vice President, Chief Marketing Officer of eBay from November 2010 to March 2015. Ms. Parham was responsible, globally, for eBay brand strategy and brand marketing, to reach over 108+ million active eBay users, Internet marketing and for customer relationship management. Prior to joining eBay, Ms. Parham served as head of Global Marketing Innovation and Initiatives and head of Global Marketing Services at Visa, Inc. from 2008 to 2010. Ms. Parham founded and serves as Executive Chairman of the Board of Directors for Shyn, an oral care product company since January 2018. Her experience also includes 13 years at Digitas, Inc., a leading marketing agency, where she held a variety of senior leadership roles, including senior vice president and general manager of the agency’s Chicago office. Ms. Parham holds Bachelor of Science degrees in Business Administration and Design Arts from Drexel University. Skills and Qualifications • Extensive senior-level executive experience, including in corporate finance, and mergers and acquisitions • More than 20 years of global strategy and marketing experience, as well as expertise in understanding consumers and the consumer decision journey Committees: • Compensation and Human Capital Committee (Chair) • Nominating and Corporate Governance Committee Current Public Company Board Experience: • Best Buy Co., Inc. Previous Public Company Board Experience: • Scripps Network Interactive Inc. • e.l.f. Beauty, Inc. Other Current Relevant Experience: • Drexel University, Board of Trustees | |||
Kirsten M. Kliphouse has served as a director of the Company since October 2022. Ms. Kliphouse previously served as the President of Google Cloud Americas, a position she held from March 2022 to July 2023, where she was responsible for leading and growing the sales, go-to-market, customer engagement, channel, and services organizations. At Google Cloud, she also served as the Global Chair of the Aspiring Leadership Academy and Women@Google Cloud. Prior to her position as President, Ms. Kliphouse served as President of the North American division of Google Cloud from June 2019 to March 2022. Prior to Google Cloud, Ms. Kliphouse was Senior Vice President at Red Hat, Inc., a subsidiary of International Business Machines Corporation, Chief Executive Officer of Yardarm Technologies, a hardware and software solutions company, and founder and Chief Executive Officer of Scaling Ventures, a technology investment and advisory firm. Prior to her position at Yardarm, Ms. Kliphouse spent more than 25 years at Microsoft, Inc., where she was part of the executive leadership team and held numerous executive positions in Enterprise Sales, Original Equipment Manufacturers (OEM), Partner and Channels, and as Corporate Vice President of Customer Support, Success and Professional Services, during which she led more than 10,000-employees globally. Ms. Kliphouse is a recipient of the Founders Award for her superior leadership and contributions to the business. Ms. Kliphouse holds a Bachelor of Science in Computer Information Sciences and Business from Muhlenberg College. | |||
Kerrii B. Anderson has served as a director of the Company since May 2006. Ms. Anderson was Chief Executive Officer of Wendy’s International, Inc., a restaurant operating and franchising company, from April 2006 until September 2008, when the company merged with Triarc. Ms. Anderson served as Executive Vice President and Chief Financial Officer of Wendy’s International from 2000 to 2006. Prior to this position, she was Chief Financial Officer, Senior Vice President of M/I Schottenstein Homes, Inc. from 1987 to 2000. Ms. Anderson holds a Bachelor of Arts in Business Administration from Elon University and a Master of Business Administration from the Fuqua School of Business at Duke University and is a Certified Public Accountant. | |||
Kathryn E. Wengel has served as a director of the Company since March 2021. Ms. Wengel currently serves as Executive Vice President, Chief Technical Operations and Risk Officer, and a member of the Executive Committee of Johnson & Johnson. Since joining Johnson & Johnson in 1988, Ms. Wengel has served in various positions of increasing responsibility across the enterprise, both in the United States and various locations globally, including Executive Vice President and Chief Global Supply Chain Officer from 2018 to January 2023, Worldwide Vice President, Chief Global Supply Chain Officer from March 2014 to July 2018, and Chief Quality Officer from April 2010 to March 2014. Ms. Wengel holds a Bachelor of Science in Civil Engineering and operations research from Princeton University. | |||
Jeffrey A. Davis has served as a director of the Company since December 2019 and Chairman of the Audit Committee since June 2023. Mr. Davis previously served as the Chief Financial Officer of Dollar Tree, Inc., a leading operator of discount variety stores, from October 2022 to March 2025. Prior to his time at Dollar Tree, Inc., Mr. Davis served as Chief Financial Officer of Qurate Retail Group, a leading retailer and media conglomerate comprised of eight retail brands including QVC, HSN, and Zulily from October 2018 through August 2022. Prior to Qurate Retail Group, Mr. Davis served as Chief Financial Officer of J. C. Penney Company Inc., a retail company, from July 2017 until September 2018. Prior to joining J. C. Penney, Mr. Davis served as Chief Financial Officer of Darden Restaurants, Inc., a restaurant operator, from July 2015 until March 2016 and Chief Financial Officer of the Walmart U.S. segment of Walmart Inc. from January 2014 to May 2015, and in various other positions of increasing responsibility at Walmart U.S. from 2006 to 2013. Mr. Davis’ experience also includes nine years in senior executive roles at Lakeland Tours LLC and McKesson Corporation. Mr. Davis is a certified public accountant and holds a Bachelor of Science in Accounting from the Pennsylvania State University and a Master of Business Administration from the Joseph M. Katz Graduate School of Business at the University of Pittsburgh. | |||
D. Gary Gilliland has served as a director of the Company since April 2014. Dr. Gilliland has served as President and Director Emeritus of the Fred Hutchinson Cancer Center, a research organization, since January 2020. From January 2015 to January 2020, Dr. Gilliland previously served as President and Director of the Fred Hutchinson Cancer Center. Prior to that, he was the inaugural Vice Dean and Vice President for Precision Medicine at the University of Pennsylvania Perelman School of Medicine from October 2013 to January 2015, where he was responsible for synthesizing research and clinical-care initiatives across all medical disciplines including cancer, heart and vascular medicine, neurosciences, genetics, and pathology, to create a national model for the delivery of precise, personalized medicine. From 2009 until he joined Penn Medicine in 2013, Dr. Gilliland was Senior Vice President of Merck Research Laboratories and Oncology Franchise Head. At Merck, Dr. Gilliland oversaw first-in-human studies, proof-of-concept trials, and Phase II/III registration trials that included the development of pembrolizumab (anti-PD1) for treatment of cancer, and managed all preclinical and clinical oncology-licensing activities. Prior to joining Merck, Dr. Gilliland was a member of the faculty at Harvard Medical School for nearly 20 years, where he served as Professor of Medicine and a Professor of Stem Cell and Regenerative Biology. He was also an Investigator of the Howard Hughes Medical Institute from 1996 to 2009, Director of the Leukemia Program at the Dana-Farber/Harvard Cancer Center from 2002 to 2009, and Director of the Cancer Stem Cell Program of the Harvard Stem Cell Institute from 2004 to 2009. Dr. Gilliland has a Doctor of Philosophy in Microbiology from UCLA and a Doctor of Medicine from UCSF. | |||
Adam H. Schechter has served as a director of the Company since April 2013, President and Chief Executive Officer of the Company since November 2019, and Chairman of the Board since May 2020. Prior to that, Mr. Schechter was President of Global Human Health and an Executive Vice President of Merck & Co., Inc., a pharmaceutical company, from 2010 to 2018, where he was a member of Merck’s executive committee. He served as special advisor to the CEO of Merck from January 2019 to July 2019. Prior to becoming President, Global Human Health, Mr. Schechter served as President, Global Pharmaceutical Business from 2007 to 2010. Mr. Schechter holds a bachelor’s degree in biology from La Salle University and was awarded an honorary Doctor of Humane Letters degree from La Salle University in 2021. |
Name and Principal Position |
Year |
Salary ($) |
Bonus ($) |
Non-Qualified Stock Options ($) |
Stock Awards ($) |
Non-Equity Incentive Plan Compensation ($) |
Change in Pension Value and Nonqualified Deferred Compensation Earnings ($) |
All Other Compensation ($) |
Total ($) |
||||||||||||||||||||||||||||||||||||
ADAM H. SCHECHTER President and Chief Executive Officer |
2024 | $ | 1,416,077 | $ | - | $ | 3,015,965 | $ | 12,162,271 | $ | 2,113,816 | $ | - | $ | 619,225 | $ | 19,327,354 | ||||||||||||||||||||||||||||
2023 | $ | 1,373,692 | $ | - | $ | 2,250,072 | $ | 9,071,320 | $ | 2,346,018 | $ | - | $ | 938,253 | $ | 15,979,355 | |||||||||||||||||||||||||||||
2022 | $ | 1,317,500 | $ | - | $ | 2,142,125 | $ | 9,063,244 | $ | 1,675,221 | $ | - | $ | 729,207 | $ | 14,927,297 | |||||||||||||||||||||||||||||
JULIA A. WANG Executive Vice President and Chief Financial Officer |
2024 | $ | 55,769 | $ | - | $ | 638,067 | $ | 2,668,417 | $ | - | $ | - | $ | 133 | $ | 3,362,386 | ||||||||||||||||||||||||||||
BRIAN J. CAVENEY Executive Vice President and President, Early Development Research Laboratories and Chief Medical and Scientific Officer |
2024 | $ | 660,769 | $ | - | $ | 451,666 | $ | 1,825,122 | $ | 604,039 | $ | - | $ | 26,161 | $ | 3,567,757 | ||||||||||||||||||||||||||||
2023 | $ | 617,635 | $ | - | $ | 432,955 | $ | 1,745,352 | $ | 609,719 | $ | - | $ | 70,782 | $ | 3,476,443 | |||||||||||||||||||||||||||||
2022 | $ | 538,000 | $ | - | $ | 343,045 | $ | 1,440,880 | $ | 641,792 | $ | - | $ | 44,750 | $ | 3,008,467 | |||||||||||||||||||||||||||||
ANITA Z. GRAHAM Executive Vice President and Chief Human Resources Officer |
2024 | $ | 569,154 | $ | 500,000 | $ | 218,548 | $ | 890,976 | $ | 481,437 | $ | - | $ | 25,432 | $ | 2,685,547 | ||||||||||||||||||||||||||||
2023 | $ | 420,000 | $ | 500,000 | $ | 196,708 | $ | 1,012,330 | $ | 405,331 | $ | - | $ | 21,622 | $ | 2,555,991 | |||||||||||||||||||||||||||||
MARK S. SCHROEDER Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer |
2024 | $ | 660,769 | $ | - | $ | 502,661 | $ | 2,027,426 | $ | 678,718 | $ | 280 | $ | 116,453 | $ | 3,986,307 | ||||||||||||||||||||||||||||
2023 | $ | 617,635 | $ | - | $ | 461,625 | $ | 1,892,720 | $ | 718,807 | $ | 13,815 | $ | 90,506 | $ | 3,795,108 | |||||||||||||||||||||||||||||
2022 | $ | 538,000 | $ | - | $ | 343,045 | $ | 1,440,880 | $ | 456,051 | $ | - | $ | 65,079 | $ | 2,843,055 | |||||||||||||||||||||||||||||
GLENN A. EISENBERG Executive Vice President and Former Chief Financial Officer |
2024 | $ | 830,462 | $ | - | $ | 655,645 | $ | 2,634,274 | $ | 826,440 | $ | - | $ | 55,087 | $ | 5,001,908 | ||||||||||||||||||||||||||||
2023 | $ | 805,462 | $ | - | $ | 615,878 | $ | 2,473,816 | $ | 917,054 | $ | - | $ | 144,567 | $ | 4,956,777 | |||||||||||||||||||||||||||||
2022 | $ | 780,500 | $ | - | $ | 586,988 | $ | 6,551,496 | $ | 661,630 | $ | - | $ | 101,879 | $ | 8,682,493 |
No Customers Found
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|---|---|---|
Schechter Adam H | - | 98,962 | 0 |
EISENBERG GLENN A | - | 31,289 | 0 |
BERBERIAN LANCE | - | 19,697 | 0 |
BERBERIAN LANCE | - | 15,921 | 0 |
ANDERSON KERRII B | - | 13,166 | 144 |
Kirchgraber Paul R | - | 12,946 | 0 |
Gilliland Dwight Gary | - | 8,656 | 0 |
van der Vaart Sandra D | - | 7,605 | 0 |
Schroeder Mark S | - | 6,687 | 0 |
Schroeder Mark S | - | 4,960 | 0 |
Summy Amy B. | - | 4,544 | 0 |
Oyegunwa Akinbolade | - | 3,464 | 0 |
Bailey Megan D. | - | 3,403 | 0 |
DiVincenzo Jonathan P. | - | 3,401 | 0 |
DiVincenzo Jonathan P. | - | 3,355 | 0 |
van der Vaart Sandra D | - | 2,171 | 0 |
Wilkinson Peter J | - | 2,087 | 0 |
Wilkinson Peter J | - | 2,054 | 0 |
Summy Amy B. | - | 1,669 | 0 |
Rothman Paul | - | 717 | 0 |
Kliphouse Kirsten Marie | - | 372 | 0 |